Recurrent gene fusions in prostate cancer
US10041123B2 · kind B2 · utility
0Cited by
54References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2007 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Mar 31, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Recurrent gene fusions in prostate cancer of androgen regulated genes or housekeeping genes and ETS family member genes are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.